Login
$TVRD
$1.10 -$0.08 (6.78%) Live

Ownership

13F as of Q2 2026 · 12.7M shares outstanding

Who owns TVRD?

By type of holder
Institutions 17.3% Insiders 10.4% Everyone else 72.3%
Concentration Top 10 holders own 23.3%
Slate Path Capital LP 5.6% · Wirk Shaheen 3.5%
Institutional ownership
17.3%
-4.0 pts vs last qtr
Institutional holders
56
-11 vs last qtr
Net shares bought
−509.4K
by institutions in Q2 2026
New / sold out
11 / 22
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • UBS Group AG +60.7K
  • Russell Investments Group, Ltd. +19.9K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • BlackRock, Inc. −292.6K
  • Geode Capital Management, LLC −92.0K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Tvardi Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+242.4%
+14.65% a year
Each share's claim on the business
−70.8%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $99.4M
over 10 fiscal years
Diluted shares, split-adjusted
2.2M5.0M7.9M2016: 2.3M shares'162017: 2.6M shares'172018: 3.0M shares'182019: 3.6M shares'192020: 4.0M shares'202021: 4.2M shares'212022: 4.5M shares'222023: 4.5M shares'232024: 2.6M shares'242025: 7.8M shares'25
Buybacks Stock-based comp
$0$10.4M$20.8M2016 buybacks: $02016 stock comp: $2.8M'162017 buybacks: $02017 stock comp: $5.8M'172018 buybacks: $02018 stock comp: $9.5M'182019 buybacks: $02019 stock comp: $12.6M'192020 buybacks: $02020 stock comp: $14.8M'202021 buybacks: $02021 stock comp: $20.8M'212022 buybacks: $02022 stock comp: $17.7M'222023 buybacks: $02023 stock comp: $13.7M'232024 buybacks: $02024 stock comp: $319.0K'242025 buybacks: $02025 stock comp: $1.4M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years37% 3–5 years4% 1–3 years36% Under 1 year22%
Quarterly turnover
16.3%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting TVRD on Form 13F
SP
Slate Path Capital LP
Shares
704.1K
% of company
5.56%
Change vs last qtr
Unchanged
Held since
2025
B
BlackRock, Inc.
Shares
95.5K
% of company
0.75%
Change vs last qtr
−292.6K (−75.4%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Tvardi Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting TVRD on Form N-PORT; together they hold 4.8% of the company
VT
Position value
$491K
% of company
2.04%
% of the fund
0.00%
As of
June 30, 2026
FS
Fidelity Salem Street Trust
Position value
$186K
% of company
0.47%
% of the fund
0.00%
As of
April 30, 2026

23 more funds behind a free account

See every fund holding Tvardi Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
WS
Wirk Shaheen
Insider
Shares
439.2K
% of company
3.47%
Change vs last qtr
—
Held since
—
TS
Tweardy Samuel David
Insider
Shares
315.7K
% of company
2.49%
Change vs last qtr
—
Held since
—

5 more holders behind a free account

See every insider and 5%+ holder of Tvardi Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support